Cassie Jung

Companies

• Aquestive Therapeutics, Inc.Chief operating officer Nov 27, 2024 to now¹
• Aquestive Therapeutics, Inc.SVP, Operations Jan 11, 2023 to Oct 2, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAquestive Therapeutics, Inc. AQST208,833 shares³$784.2K at $3.75Sep 8, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 3, 2026Exercised 4,587 shares at $0.96 of Aquestive Therapeutics, Inc.³
• May 5, 2026Shares withheld for tax 72,734 shares at $4.18 of Aquestive Therapeutics, Inc.⁴
• Mar 10, 2026Sold 45,791 shares at $4.17 of Aquestive Therapeutics, Inc.⁵
• Mar 9, 2026Granted 80,000 shares of Aquestive Therapeutics, Inc.⁵
• Oct 15, 2025Sold 67,575 shares at $7.01 of Aquestive Therapeutics, Inc.⁶
• Oct 15, 2025Exercised options 25,000 shares at $3.10 of Aquestive Therapeutics, Inc.⁶
• Sep 4, 2025Sold 62,180 shares at $5.00 of Aquestive Therapeutics, Inc.⁷
• Sep 4, 2025Exercised options 25,000 shares at $0.71 of Aquestive Therapeutics, Inc.⁷
• Sep 4, 2025Exercised options 25,000 shares at $3.15 of Aquestive Therapeutics, Inc.⁷
• Mar 10, 2025Shares withheld for tax 2,182 shares at $2.54 of Aquestive Therapeutics, Inc.⁸
• Mar 9, 2025Shares withheld for tax 7,997 shares at $2.65 of Aquestive Therapeutics, Inc.⁸
• Mar 7, 2025Shares withheld for tax 7,361 shares at $2.65 of Aquestive Therapeutics, Inc.⁸
• Mar 7, 2025Granted 80,000 shares of Aquestive Therapeutics, Inc.⁸
• Nov 26, 2024Sold 44 shares at $4.87 of Aquestive Therapeutics, Inc.⁹
• Mar 10, 2024Shares withheld for tax 1,132 shares at $4.88 of Aquestive Therapeutics, Inc.¹⁰
• Mar 9, 2024Shares withheld for tax 8,300 shares at $4.88 of Aquestive Therapeutics, Inc.¹⁰
• Mar 9, 2024Shares withheld for tax 14,120 shares at $4.88 of Aquestive Therapeutics, Inc.¹¹
• Mar 7, 2024Granted 101,250 shares of Aquestive Therapeutics, Inc.¹²
• Mar 10, 2023Shares withheld for tax 1,365 shares of Aquestive Therapeutics, Inc.¹²
• Mar 9, 2023Granted 110,000 shares of Aquestive Therapeutics, Inc.¹³